Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Shutterly currently holds 11,372 shares of Altimmune, Inc. (ALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Shutterly has been a net neutral trader of ALT stock. They have purchased $0 and sold $0 worth of shares.
Andrew Shutterly's most recent insider trade was on Jul 31, 2024, when they sold 1,259 shares at $5.41 per share.
Andrew Shutterly serves as Executive at Altimmune, Inc. (ALT). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Andrew Shutterly holds the position of Executive at Altimmune, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Andrew Shutterly has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Andrew Shutterly was on Jul 31, 2024, when they purchased $6.8K worth of ALT shares. This transaction involved 1,259 shares at $5.41 per share.
Andrew Shutterly currently owns 11,372 shares of Altimmune, Inc. (ALT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Shutterly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Shutterly has 1 Form 4 filings on record as an insider at Altimmune, Inc..
Set alerts for Andrew Shutterly and 40,000+ other insiders.